Evaluation of complication rates of meglumine diatrizoate and meglumine iothalamate in cerebral angiography.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001930:Brain Injuries / Q000000981:diagnostic imaging; D001932:Brain Neoplasms / Q000000981:diagnostic imaging; D002533:Cerebral Angiography; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000633:toxicity*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D007483:Iothalamic Acid; D008297:Male; D008875:Middle Aged; D013345:Subarachnoid Hemorrhage / Q000000981:diagnostic imaging
D003287:Contrast Media; D007483:Iothalamic Acid